Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9149 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9014 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8921 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8921 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8857 |
High Similarity |
NPD1549 |
Phase 2 |
0.8851 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD2800 |
Approved |
0.8784 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD1240 |
Approved |
0.8649 |
High Similarity |
NPD7411 |
Suspended |
0.8643 |
High Similarity |
NPD1510 |
Phase 2 |
0.8633 |
High Similarity |
NPD1607 |
Approved |
0.8633 |
High Similarity |
NPD6651 |
Approved |
0.8609 |
High Similarity |
NPD7075 |
Discontinued |
0.8592 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD2796 |
Approved |
0.8581 |
High Similarity |
NPD4380 |
Phase 2 |
0.8533 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8403 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8323 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8322 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8311 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8299 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8289 |
Intermediate Similarity |
NPD2801 |
Approved |
0.828 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8252 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8243 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8243 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8224 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8219 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8219 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8151 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8085 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8013 |
Intermediate Similarity |
NPD920 |
Approved |
0.7987 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7842 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7834 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7817 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7793 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7793 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7758 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.773 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD943 |
Approved |
0.7708 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7676 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7662 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7651 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7625 |
Intermediate Similarity |
NPD919 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7572 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7571 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7517 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD411 |
Approved |
0.7439 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7432 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7429 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7391 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7361 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD17 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7285 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD1201 |
Approved |
0.72 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3446 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1470 |
Approved |
0.712 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7013 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.6994
|
Remote Similarity |
NPD7577 |
Discontinued |